Unlimited Opportunity in the World's Second Largest Country

And experts who can guide you through even the most complex study

  • Staffed office in Bangalore since 2002
  • Provides coverage to Sri Lanka and Bangladesh, as well
  • On-site staff provide expertise in Clinical Operations, Project Management, Medical Writing, Biostatistics and Data Management services

SEE OUR CAPABILITIES >>

India

Additional Resources & Thought Leadership About Conducting Trials in India


 

 

One Billion Reasons to Study Here

One Billion Reasons to Study Here

Massive population means ample enrollment opportunities

  • Over 1 billion people; the world’s second largest country, but oldest civilization
  • Indian people have 6 to 7 advantageous genetic populations
  • All major races are represented in India with Caucasian being the most prevalent
  • Average life expectancy is 69 to 70 years
Unmet Health Needs for Acute and Chronic Diseases

Unmet Health Needs for Acute and Chronic Diseases

India has approximately 16% of the global population, but about 20% of the global disease burden

  • Huge increase in lifestyle disorders, as well
  • Concentrated urban centers, and the state-of-the-art hospitals and referral centers in them, aid in patient access and enrollment rates


     

 

 

 

Taking Care of Business

Taking Care of Business

Making Strides to make clinical research more accessible

  • The Ministry of Health, the DCG office, various industry bodies and other stakeholders worked hard to get research back into the country
  • Practical guidelines, realistic approval timelines and sensible review processes are now in place
  • Pharm-Olam never left India, and its experienced, native staff are not just up-to-date on the country’s offerings – but live there and bring the native knowledge to your study
From our Leader on the Ground

From our Leader on the Ground

Country Manager, Thanuja Naidu

"The process is much more streamlined now. So now we know for any particular research we have to conduct in India, which division we have to go. If we have to do a market registration, then there is a cell that we need to go to and do market registration. And when it comes to new drug evaluation division, we do have a biological drug division, non-biological drug division, medical devices and diagnostics. We have been working in India for over half of our twenty plus years. We intimately understand every step of the process for successful research in India."

See why working with Pharm-Olam in India could be the best choice for your next study.


Contact Us